keten, d. Et Al. 2017. NS3 Inhibitor Developed Cross Resistance with Triple Therapy in Hepatitis C Patients. A Case Report. Molecular Characterization of Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey.. APASL Annual Meeting 2017 , (Shanghai, China).

keten, d., SAYAN, M., AYGEN, B., & AKHAN, S., (2017). NS3 Inhibitor Developed Cross Resistance with Triple Therapy in Hepatitis C Patients. A Case Report. Molecular Characterization of Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey. . APASL Annual Meeting 2017, Shanghai, China

keten, derya Et Al. "NS3 Inhibitor Developed Cross Resistance with Triple Therapy in Hepatitis C Patients. A Case Report. Molecular Characterization of Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey.," APASL Annual Meeting 2017, Shanghai, China, 2017

keten, derya Et Al. "NS3 Inhibitor Developed Cross Resistance with Triple Therapy in Hepatitis C Patients. A Case Report. Molecular Characterization of Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey.." APASL Annual Meeting 2017 , Shanghai, China, 2017

keten, d. Et Al. (2017) . "NS3 Inhibitor Developed Cross Resistance with Triple Therapy in Hepatitis C Patients. A Case Report. Molecular Characterization of Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey.." APASL Annual Meeting 2017 , Shanghai, China.

@conferencepaper{conferencepaper, author={derya keten Et Al. }, title={NS3 Inhibitor Developed Cross Resistance with Triple Therapy in Hepatitis C Patients. A Case Report. Molecular Characterization of Hepatitis B Viruses Isolated from Chronically Infected Patients in Turkey.}, congress name={APASL Annual Meeting 2017}, city={Shanghai}, country={China}, year={2017}}